CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
BoneOscopy is developing a novel technology to monitor bone cancer during particle radiotherapy. By detecting gamma emissions from tumors, this system aims to provide daily insights into treatment effectiveness, enhancing personalized care and improving outcomes for patients undergoing proton and carbon ion therapies.
Metastatic bone cancer is an incurable disease and one of the most complex cancers to treat.
Due to the high dose, tumour imaging is currently performed at the beginning and end of standard particle radio-therapy (PRT), making personalised treatment difficult.
The main goal of BoneOscopy is to develop a radically new technology to enable informed medical decisions by monitoring bone cancer on a daily basis during PRT.
At the heart of BoneOscopy is the ability to detect prompt gamma (PGs) emitted…
DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Slovenia, Ljubljana
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
TECHNISCHE HOCHSCHULE MITTELHESSEN
Germany, Giessen
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
